These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18690510)

  • 1. Epidemiological, clinical, and therapeutic aspects of primary intracerebral hemorrhage.
    Ciccone A; Pozzi M; Motto C; Tiraboschi P; Sterzi R
    Neurol Sci; 2008 Sep; 29 Suppl 2():S256-7. PubMed ID: 18690510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa plus surgery for intracerebral hemorrhage.
    Sutherland CS; Hill MD; Kaufmann AM; Silvaggio JA; Demchuk AM; Sutherland GR
    Can J Neurol Sci; 2008 Nov; 35(5):567-72. PubMed ID: 19235439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).
    Steiner T; Vincent C; Morris S; Davis S; Vallejo-Torres L; Christensen MC
    J Stroke Cerebrovasc Dis; 2011; 20(4):287-94. PubMed ID: 20452785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
    Hoffmann T; Assmann A; Dierksen A; Roussel E; Ullrich S; Lichtenberg A; Albert A; Sixt S
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled off-label use of recombinant activated factor VII (NovoSeven) can build evidence base.
    Cardiovasc J Afr; 2008; 19(1):52-4. PubMed ID: 18320092
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA
    Stroke; 2007 Feb; 38(2 Suppl):763-7. PubMed ID: 17261734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
    Jiang C; Wang J; Wang J; Zhang J;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the risk of ICH enlargement.
    Wartenberg KE; Mayer SA
    J Neurol Sci; 2007 Oct; 261(1-2):99-107. PubMed ID: 17631908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of Severe Coagulopathy and Hyperfibrinolysis by Tranexamic Acid and Recombinant Factor VIIa in a Cirrhotic Patient After Trauma: A Case Report.
    Louro J; Andersen K; Dudaryk R
    A A Case Rep; 2017 Sep; 9(5):144-147. PubMed ID: 28509781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model.
    Bonhomme F; Lecompte T; Samama CM; Godier A; Fontana P
    Eur J Anaesthesiol; 2018 Mar; 35(3):208-214. PubMed ID: 29334511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
    Mazer CD; Leong-Poi H; Mahoney J; Latter D; Strauss BH; Teitel JM
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control.
    Sorimachi T; Fujii Y; Morita K; Tanaka R
    J Neurosurg; 2007 Feb; 106(2):250-4. PubMed ID: 17410708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.
    Chuansumrit A; Isarangkura P; Angchaisuksiri P; Sriudomporn N; Tanpowpong K; Hathirat P; Jorgensen LN
    Haemophilia; 2000 Mar; 6(2):61-5. PubMed ID: 10781189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-associated intracerebral hemorrhage.
    Cavallini A; Fanucchi S; Persico A
    Neurol Sci; 2008 Sep; 29 Suppl 2():S266-8. PubMed ID: 18690514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
    Mayer SA
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S235-40. PubMed ID: 12404092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage.
    Illanes S; Zhou W; Schwarting S; Heiland S; Veltkamp R
    Stroke; 2011 Jan; 42(1):191-5. PubMed ID: 21127298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-early hemostatic therapy for intracerebral hemorrhage.
    Mayer SA
    Stroke; 2003 Jan; 34(1):224-9. PubMed ID: 12511778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.